Recursion Pharmaceuticals Summit Therapeutics: 2026 Insight
Two biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
This guide weighs the advantages and drawbacks of target date versus lifecycle funds to help you pick the option that best fits your retirement plan.
25,428 articlesTwo biotech contenders, Recursion Pharmaceuticals and Summit Therapeutics, face off in a year of uncertainty and oppo...
A breakout multiple sclerosis drug can change a biotech's trajectory. This article digs into an $8 million investment...
As electricity demand climbs, NuScale Power presents a rare risk reward. This piece lays out one compelling buy reaso...
Signet Jewelers stock just moved higher as the company rolls out a growth strategy focused on core brands and smarter...
After a dramatic fall, Canopy Growth has staged a cautious comeback. This article breaks down whether canopy growth s...
Reliance Industries sits at the center of India’s growth story. This guide breaks down reliance (rs) 2025 earnings ex...
Uber's move to back Rivian could reshape both companies' futures and the EV/autonomy landscape. This guide breaks dow...
Markets can stay calm even when prices rise, but two hidden forces often lurk beneath the surface. This guide identif...
The Fed has stopped cutting rates, but that doesn’t mean investors should abandon Realty Income. This article explain...
Disney delivered a strong quarter that sent its stock higher. This article breaks down the earnings, the drivers behi...
When prices surge, some firms enjoy sudden profits. This piece explains why the corporate income tax already taxes th...
OpenAI has released GPT-5.6 to a limited group of users, signaling a cautious, policy-conscious rollout. This cautiou...